In Nature Communications, Fred Hutch bioengineer Matthias Stephan, MD, PhD, reports latest effort to use innovative materials to improve immune-based therapies. SEATTLE — May 29, 2024 — Foam mixed ...

Foam. That’s what Fred Hutch Cancer Center immunobioengineer Matthias Stephan, MD, PhD, pitched to Katie Fitzgerald when she interviewed for a research technician position in his lab. “He broached it ...

Foam mixed with medications is already used to treat conditions such as varicose veins, hemorrhoids, wounds on the skin and even hair loss. Now, Fred Hutch Cancer Center scientists have found that ...

In a recent study published in the journal Nature Communications, researchers in the United States investigated the benefits of liquid foam as an alternative to conventional liquid-based gene delivery ...

Bioengineers report that a foaming liquid worked better than a standard liquid formulation at transferring gene therapy components to cells in laboratory studies. Foam mixed with medications is ...

In Nature Communications, Fred Hutch bioengineer Matthias Stephan, MD, PhD, reports latest effort to use innovative materials to improve immune-based therapies. See ...